E. Regañón - Concepedia

Author

E. Regañón

Hospital Universitari i Politècnic La Fe

Also Known As

E Reganon, E Regañon, E Regañón, E Réganon, E. REGANON, E. REGAÑON, E. Reganon, E. Regañon, E. Regañón, E. Réganon

Publications

496

Citations

H-Index

Concepts

All Affiliations

Hospital Universitari i Politècnic La Fe Leitat Technological Center Hospital Universitario Doctor Peset Instituto de Investigación Sanitaria La Fe

About

E. Regañón is an author at Hospital Universitari i Politècnic La Fe specializing in medicine, hematology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	227
2	Health Sciences	2	2	28
3	Public Health	2	2	52
4	Engineering	1	1	16
5	Natural Sciences	1	1	16

E. Regañón

Publications

421

Citations

H-Index

Page 1

	Year	Citations
Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems Juan Gilabert–Estellés, Luis Ramón, Francisco España, Human Reproduction	2007	124
Alterations in the Coagulation and Fibrinolysis System in Pregnancy Labour and Puerperium, with Special Reference to a Possible Transitory State of Intravascular Coagulation during Labour J. Gilabert, José A. Aznar, Juan José Parrilla, Thrombosis and Haemostasis PathologyGynecologyIntravascular CoagulationThrombosisHematology	1978	40
Inherited Fibrinolytic Disorder Due to an Enhanced Plasminogen Activator Level J Aznar, A. Estellés, V. Vila, Thrombosis and Haemostasis ImmunologyPathologyBlood ClotThrombosisHematology	1984	40
VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer Tania Fleitas, Vicenta Martı́nez-Sales, V. Vila, Clinical & Translational Oncology OncologyMedicinePathologyBronchial NeoplasmCancer Biology	2013	35
Elevated Thrombotic Activity after Myocardial Infarction: A 2-Year Follow-Up Study Vicenta Martı́nez-Sales, V. Vila, E. Regañón, Pathophysiology of Haemostasis and Thrombosis Persistent GenerationPharmacotherapyAcute Myocardial InfarctionThrombosisVenous Thrombosis	1998	30
What is the best biomarker for diagnosis of rejection in heart transplantation? Luis Martínez‐Dolz, Luís Almenar, E. Regañón, Clinical Transplantation	2009	27
Erythrocyte membrane composition in patients with primary hypercholesterolemia Amparo Vayá, Marisa Martínez Triguero, E. Regañón, Clinical Hemorheology and Microcirculation	2008	27
Follow-up Study on the Utility of von Willebrand Factor Levels in the Diagnosis of Cardiac Allograft Vasculopathy Luis Martínez‐Dolz, Luís Almenar, E. Regañón, The Journal of Heart and Lung Transplantation ThrombosisVascular DiseaseTransplantationFollow-up StudyCardiovascular Disease	2008	23
A rapid method for isolation of fibrinogen from human plasma by precipitation with polyethylene glycol 6,000 V. Vila, E. Regañón, F. Llopis, Thrombosis Research Polyethylene Glycol 6,000BioanalysisHuman PlasmaFibrinolysisBiomedical Engineering	1985	19
Gelation of Fibrinogen in Plasma E. Regañón, V. Vila, José A. Aznar Pathophysiology of Haemostasis and Thrombosis Plasma MedicineThrombosisBioanalysisHematologyClinical Chemistry	1984	16

Page 1